Aldeyra Therapeutics (ALDX) Deferred Taxes (2019)
Aldeyra Therapeutics (ALDX) posted Deferred Taxes of -$1.3 million for Q1 2019.
Aldeyra Therapeutics (ALDX) Deferred Taxes (2019) Analysis & Trends
Aldeyra Therapeutics' Deferred Taxes history runs 1 years deep, the most recent figure standing at -$1.3 million for Q1 2019.
- Quarterly Deferred Taxes changed N/A year-over-year to -$1.3 million in Q1 2019, while the trailing twelve-month figure through Dec 2019 was -$1.3 million (changed N/A YoY) and the FY2020 annual result came in at -$479265.0, up 63.41% from the prior year.
- Deferred Taxes was -$1.3 million for Q1 2019 at Aldeyra Therapeutics.
- Across five years, Deferred Taxes topped out at -$1.3 million in Q1 2019 and bottomed at -$1.3 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Aldeyra Therapeutics | 95.00 Mn | 95.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -1.31 Mn |